New Search
If you are not happy with the results below please do another searchIn the past, biomedical research grants were often fiscal activities to advance the science in a specific field or area, acting more as simply a funding source than as a program that engages its grantees. Funders have realized that their impact can be enhanced by creating a holistic approach to funding, considering the grantee as part of their community, and providing additional resources that are not directly related to the research, but to the person awarded. This approach not only improves the experience of the grantee but provides opportunities for the grantor without a heavy cost, including communications and advocacy... read more →
This session offers an interactive exploration of the multifaceted nature of success in the context of biomedical and health research funding. Recognizing that the definition of success is not one-size-fits-all, the session will delve into how various funders, ranging from disease-specific organizations to disease-agnostic entities and spanning the spectrum from private foundations to public charities, uniquely measure their achievements. For each definition of success comes a way to measure it and this session seeks to provide an interactive avenue for sharing and discussing tools and frameworks across the HRA membership. Moderator Kevin Sia, PhD Program Officer | Doris Duke Foundation... read more →
This session explored the intricacies of supporting research through effective partnerships. Through speakers and breakout discussion, we showcased effective models–from ongoing funder collaboratives to one-off partnerships–and identify best practices and challenges. Attendees left the session with insights and tips for exploring opportunities for collaboration. Panelists presented real-life examples of successful collaborations that have contributed to advancing biomedical research. Panelists discussed practical tips on how to find and set up successful partnerships–from defining a shared vision for success, developing strategies for leveraging resources and expertise, and evolving partnerships over time. Following the panel discussion, we facilitated smaller breakout groups for a... read more →
Tuesday October 17, 2:00pm-3:45pm CT This session will discuss how biomedical research funding trends and priorities have evolved and continue to adapt. This session will discuss how the rising costs of research impacts what funders are doing, how funders have changed who they are funding in terms of career stage, and how funders have changed what types of science they are funding. To give a broad perspective, this session will include the perspective of philanthropic organizations and venture capitalism. Moderator Kevin Sia, PhD Program Officer for Medical Research | Doris Duke Foundation Presenters Cara Altimus, PhD Senior Director | Milken... read more →
Tuesday October 17, 9:00am-10:00am CT When a funding organization has a strategic plan, that plan is expressed through the execution of its funding program(s). When an organization develops new strategic directions or objectives, then it is often necessary to design and implement new funding programs to pursue them. This session aims to examine and discuss real-world examples of this, including how programs were designed to fit the new purpose, how they were implemented and how their success was measured. Moderator Kevin Sia, PhD Program Officer for Medical Research | Doris Duke Foundation Presenters Shawna Strickland, PhD Associate Executive Director, Programs... read more →
Wednesday March 22, 10:00am-11:15am PT In this session we explored how funders assess and evaluate competing proposals to maximize the eventual impact and advance funders’ missions. In addition, when it’s all done (X-years later), how do funders measure that impact and test if our prognostic methods actually work? This session featured an external speaker who described the extensive analysis on the value of various metrics as predictors of success. In addition, HRA members shared metrics they use (outside of just publications and funding) and any evidence they have as to whether these metrics are valuable in choosing candidates who will... read more →
Topic: Advocating for your Registry/Biorepository with your Board Description: We all have (or may have to in the future) needed to justify the cost and strategy involved in our registry/biorepository programs to a governing Board or other leadership. Durghis session members came prepared to hear about examples in the following areas and discuss their own experiences: risk v reward in program launch or growth, program sustainability, external partnerships, and others. Informal presentations wasbe provided by the Barth Syndrome Foundation, PKD Foundation, and TSC Alliance.
Dear HRA members, We have a few exciting announcements before listing Upcoming Events and Member Resources. Welcome to HRA’s newest staff member – Jenna Hicks! Jenna is our new Inclusive Grantmaking Initiative Project Lead and Civic Science Associate. We thank the Doris Duke Foundation and the Rita Allen Foundation for their generous support of the IGI. Also, please help me welcome our newest HRA member organizations! 1907 Foundation Jane Coffin Childs Memorial Fund for Medical Research Pancreatic Cancer Action Network I am also very excited to announce that as part of our EVO program, HRA is now a... read more →
Annual report: a document written and released to inform an organization’s community or to the public by an organization to describe activities related to its funding and/or grant activities. Conversely, an annual report or a progress report can also be requested or required by a funder for the grantee to report scientific progress. Progress report periods can be defined by the funder at their discretion Blinding: also known as masking; the act of deidentifying any information that may introduce bias that could influence results. Bylaws: the rules or the operating manual by which an organization follows. These can include... read more →